Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies
- 31 August 2013
- journal article
- research article
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 23 (8), 931-940
- https://doi.org/10.1016/j.euroneuro.2012.09.008
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging StudyAmerican Journal of Psychiatry, 2011
- Glycine Transporter Inhibitor Attenuates the Psychotomimetic Effects of Ketamine in Healthy Males: Preliminary EvidenceNeuropsychopharmacology, 2011
- The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndromeSchizophrenia Research, 2010
- N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?Brain Research Bulletin, 2010
- High dose D-serine in the treatment of schizophreniaSchizophrenia Research, 2010
- Probably at-risk, but certainly ill — Advocating the introduction of a psychosis spectrum disorder in DSM-VSchizophrenia Research, 2010
- Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal StudySchizophrenia Bulletin, 2009
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common PathwaySchizophrenia Bulletin, 2009
- North American Prodrome Longitudinal Study: A Collaborative Multisite Approach to Prodromal Schizophrenia ResearchSchizophrenia Bulletin, 2007
- Caution Regarding the Use of Pilot Studies to Guide Power Calculations for Study ProposalsArchives of General Psychiatry, 2006